Statistics for Bioventus (id:8384 BVS)

Valuation metrics

Market cap

773.95M

Enterprise value

1.13B

Trailing P/E (ttm)

-4.58

Forward P/E

16.91

PEG ratio

16.91

Price/Sales (ttm)

1.39

Price/Book (mrq)

4.90

Enterprise Value/Revenue

2.04

Enterprise Value/EBITDA

22.42

Overview

Shares outstanding

65.37M

Float

35.56M

Shares short

1.34M

% Held by insiders

0.11%

% Held by institutions

0.72%

Average volume (10 days)

682.75K

Average volume (90 days)

Price summary

52-Week low

3.77

52-Week high

14.38

52-Week change

65.47%

Beta

0.88

50-Day moving average

11.87

200-Day moving average

7.45

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-7.11%

Operating margin

4.78%

Operational effectiveness

Return on assets

2.48%

Return on equity

-24.76%

Income statement

Revenue (ttm)

8.68

Revenue per share (ttm)

8.68

Quarterly revenue growth (yoy)

Gross profit (ttm)

328.19M

EBITDA

68.32M

Net income to common (ttm)

-39,482,000.00

Diluted EPS (ttm)

-0.57

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

43.07M

Total cash per share (mrq)

0.66

Total debt (mrq)

405.07M

Total Debt/Equity (mrq)

216.81

Current ratio (mrq)

141.20%

Book value per share (mrq)

2.28

Cash flow

Cash flow statement

29.85M

Levered free cash flow (LFCF)

28.37M